CVE-2026-52866: Apollo Pharmacy Blood Glucose Monitoring System Model No. Apg-01 Bt

Medium severity, CVSS 6.5. EPSS: 0.3% chance of exploitation in the next 30 days.

An attacker within BLE communication range can monopolize the device's only available BLE connection slot, preventing legitimate users or applications from establishing a connection.

Affected products

• Apollo Pharmacy Blood Glucose Monitoring System Model No. Apg-01 Bt: version 0x0110_v1.1.0 only

Published 2026-06-19. Last modified 2026-06-22.